Tag Archives: Option B+

Option B+: In obstacle courses to lifelong antiretroviral treatment, hurdles are higher for pregnant women, study says

By on .

Work conflicts, hidden HIV status, and bad treatment by staff are among the hurdles keeping women living with HIV from continuing antiretroviral treatment for life following childbirth, according to a article published last month ahead of print in the Journal of Acquired Immune Deficiency Syndromes. The study described in “What they wanted was to give […]

A modest proposal and mixed messages, treatment for mothers, and counting TB

By on .

After filling our heads with numbers this week in the wake of the Obama administration’s release of its FY 14 budget request, we’ll keep it simple, with a picture that’s worth a thousand words, some recent pieces that remind us of what the fraction of a percent of the budget spent on global health can […]

Study: In Malawi lifelong antiretroviral treatment for expectant moms “translates into saving more than 250,000 maternal life years”

By on .

One or two years ago, the idea was radical for low-resource settings: Provide antiretroviral treatment for life for all women who were pregnant and HIV positive, thus protecting the health not only of the infants on the way, but of their future siblings, and of the mothers themselves, as well as their partners. Since 2010 […]

ART for life looks promising for women of Malawi

By on .

Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — Striking data on early outcomes from 18 months […]

India’s patent laws, public health response without public healthcare and bridging the Global Fund gap . . .

By on .

India’s patent laws: This Lancet special report on legal challenges by Bayer and Novartis to applications of India’s Patents Act provides a link to the 2010 United Nations Development Program’s report on the nation’s efforts to supply affordable HIV treatment in the context of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It […]

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]